|Omnicell Inc -- USA Stock|| |
USD 50.5 0.35 0.69%
Executive VP of Strategy and Bus. Devel.
Mr. Nhat H. Ngo is Executive Vice President Strategy and Business Development of Omnicell, Inc. He joined Omnicell in November 2008 as Vice President of Strategy and Business Development. In March 2012, Mr. Ngo was named Executive Vice President, Strategy and Business Development. From January 2007 to October 2008, Mr. Ngo served as Vice President of Business Development and Licensing for a business unit of Covidien, a global healthcare products company. From June 1999 to April 2006, Mr. Ngo worked at BriteSmile, Inc., a directtoconsumer aesthetic technology company and served in a variety of senior leadership positions in marketing, sales, operations, strategic planning and corporate development. From September 1997 to June 1999, Mr. Ngo practiced corporate law at Shaw Pittman, LLP.
Age: 43 EVP Since 2012
Ngo received a B.S. in commerce, with a concentration in finance, from the University of Virginia McIntire School of Commerce and a J.D. from the University of Virginia School of Law.
Nhat Ngo Latest Insider Activity
The company has return on total asset (ROA)
of (0.03) %
which means that it has lost $0.03 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (1.8) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 194.44 M in liabilities with Debt to Equity (D/E) ratio of 43.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Omnicell Inc has Current Ratio of 1.37 which is within standard range for the sector.
Omnicell, Inc. offer automation and business analytics software solutions for medication and supply management in healthcare worldwide. Omnicell Inc (OMCL) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 1,451 people. Omnicell is listed under Computers category by Fama And French industry classification.